Ph+ ALL patients in first complete remission have similar survival after reduced intensity and myeloablative allogeneic transplantation: impact of tyrosine kinase inhibitor and minimal residual diseaseVeronika Bachanová, Daniel J. Weisdorf, Marcos de Lima et al.|Leukemia|2013Cited by 136
Long-term survival outcomes of reduced-intensity allogeneic or autologous transplantation in relapsed grade 3 follicular lymphomaEvgeny Klyuchnikov, Mehdi Hamadani, Ulrike Bacher et al.|Bone Marrow Transplantation|2015Cited by 42